| Year |
Title |
Altmetric |
| 2023
|
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
Chest.
163:502-514.
2023
|
|
| 2023
|
Clinical Implications of Low Absolute Blood Eosinophil Count in the SPIROMICS COPD Cohort.
Chest.
163:515-528.
2023
|
|
| 2023
|
Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity.
Annals of the American Thoracic Society.
20:206-214.
2023
|
|
| 2023
|
Beta-blocker use in patients with chronic obstructive pulmonary disease: A systematic review: A systematic review of βB in COPD.
Trends in Cardiovascular Medicine.
33:53-61.
2023
|
|
| 2023
|
Using Community Health Advisors to Increase Lung Cancer Screening Awareness in the Black Belt: a Pilot Study.
Journal of Cancer Education.
2023
|
|
| 2022
|
Acute Exacerbations Are Associated with Progression of Emphysema.
Annals of the American Thoracic Society.
19:2108-2111.
2022
|
|
| 2022
|
Effect of chronic mucus hypersecretion on treatment responses to inhaled therapies in patients with chronic obstructive pulmonary disease: Post hoc analysis of the IMPACT trial.
Respirology.
27:1034-1044.
2022
|
|
| 2022
|
Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD.
Respiratory Research.
23.
2022
|
|
| 2022
|
A Randomized Trial of a Nurse-Led Palliative Care Intervention for Patients with Newly Diagnosed Lung Cancer.
Journal of Palliative Medicine.
25:1668-1676.
2022
|
|
| 2022
|
Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial.
American Journal of Respiratory and Critical Care Medicine.
206:838-845.
2022
|
|
| 2022
|
Lung Function and the Risk of Exacerbation in the β-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease Trial.
Annals of the American Thoracic Society.
19:1642-1649.
2022
|
|
| 2022
|
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.
New England Journal of Medicine.
387:1173-1184.
2022
|
|
| 2022
|
Time-Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial.
Journal of the American Heart Association.
11.
2022
|
|
| 2022
|
Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
2022
|
|
| 2022
|
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort An Observational Cohort Study.
American Journal of Respiratory and Critical Care Medicine.
206:554-562.
2022
|
|
| 2022
|
Lung Microbiota and Metabolites Collectively Associate with Clinical Outcomes in Milder Stage Chronic Obstructive Pulmonary Disease.
American Journal of Respiratory and Critical Care Medicine.
206:427-439.
2022
|
|
| 2022
|
Comparing Racial Differences in Emphysema Prevalence Among Adults With Normal Spirometry: A Secondary Data Analysis of the CARDIA Lung Study.
ACP journal club.
175:1118-1125.
2022
|
|
| 2022
|
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR.
Science of the Total Environment.
829.
2022
|
|
| 2022
|
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective.
Advances in Therapy.
39:2302-2322.
2022
|
|
| 2022
|
Identification of Sputum Biomarkers Predictive of Pulmonary Exacerbations in COPD.
Chest.
161:1239-1249.
2022
|
|
| 2022
|
Chronotropic index during 6-minute walk and acute respiratory events in COPDGene.
Respiratory Medicine.
194.
2022
|
|
| 2022
|
Fibrinogen mediates cadmium-induced macrophage activation and serves as a predictor of cadmium exposure in chronic obstructive pulmonary disease
2022
|
|
| 2022
|
Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers.
Chest.
161:960-970.
2022
|
|
| 2022
|
Prolonged Prone Positioning for COVID-19-induced Acute Respiratory Distress Syndrome: A Randomized Pilot Clinical Trial.
Annals of the American Thoracic Society.
19:685-687.
2022
|
|
| 2022
|
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations.
American Journal of Respiratory and Critical Care Medicine.
205:819-829.
2022
|
|
| 2022
|
Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease.
American Journal of Respiratory and Critical Care Medicine.
205:631-640.
2022
|
|
| 2022
|
Bronchial Thermoplasty in Patients With Severe Asthma at 5 Years: The Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty in Severe Persistent Asthma Study.
Chest.
161:614-628.
2022
|
|
| 2022
|
Correction to: Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study (Advances in Therapy, (2020), 37, 9, (3775-3790), 10.1007/s12325-020-01409-8).
Advances in Therapy.
39:1446.
2022
|
|
| 2022
|
Pre-chronic obstructive pulmonary disease: a pathophysiologic process or an opinion term?.
Current Opinion in Pulmonary Medicine.
28:109-114.
2022
|
|
| 2022
|
The Air We Breathe: Respiratory Impact of Indoor Air Quality in Chronic Obstructive Pulmonary Disease.
American Journal of Respiratory and Critical Care Medicine.
205:378-379.
2022
|
|
| 2022
|
Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease.
Annals of the American Thoracic Society.
19:171-178.
2022
|
|
| 2022
|
Neighborhood Socioeconomic Deprivation in Young Adulthood and Future Respiratory Health: The CARDIA Lung Study.
American Journal of Medicine.
135:211-218.e1.
2022
|
|
| 2022
|
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients.
American Journal of Respiratory and Critical Care Medicine.
205:275-287.
2022
|
|
| 2022
|
Video Telehealth Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease Is Associated with Clinical Improvement Similar to Center-based Pulmonary Rehabilitation.
Annals of the American Thoracic Society.
19:332-335.
2022
|
|
| 2022
|
Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument.
Chronic obstructive pulmonary diseases (Miami, Fla.).
9:195-208.
2022
|
|
| 2022
|
Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts.
Annals of the American Thoracic Society.
19:143-146.
2022
|
|
| 2022
|
Heart Rate Variability on 10-Second Electrocardiogram and Risk of Acute Exacerbation of COPD: A Secondary Analysis of the BLOCK COPD Trial.
Chronic obstructive pulmonary diseases (Miami, Fla.).
9:226-236.
2022
|
|
| 2022
|
Higher COPD Assessment Test Score Associated With Greater Exacerbations Risk: A Post Hoc Analysis of the IMPACT Trial.
Chronic obstructive pulmonary diseases (Miami, Fla.).
9:68-79.
2022
|
|
| 2021
|
Discordant diagnostic criteria for pneumonia in COPD trials: a review.
European Respiratory Review.
30.
2021
|
|
| 2021
|
Association between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.
Journal of the American Medical Association.
326:2287-2298.
2021
|
|
| 2021
|
Correction to: Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults (Immunity & Ageing, (2020), 17, 1, (18), 10.1186/s12979-020-00189-7).
Immunity and Ageing.
18.
2021
|
|
| 2021
|
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium
2021
|
|
| 2021
|
Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease.
Journal of Cachexia, Sarcopenia and Muscle.
12:1803-1817.
2021
|
|
| 2021
|
InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations.
Respiratory Research.
22.
2021
|
|
| 2021
|
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.
npj Biofilms and Microbiomes.
7.
2021
|
|
| 2021
|
The challenge of addressing obesity in people with poorly controlled asthma
2021
|
|
| 2021
|
Chronotropic index and acute exacerbations of chronic obstructive pulmonary disease a secondary analysis of block Copd.
Annals of the American Thoracic Society.
18:1795-1802.
2021
|
|
| 2021
|
Pneumococcal Antibody Function for Immunologic Evaluation: Normal Results in Older Adults, and a Novel Analytical Model for Vaccine Response.
Journal of Clinical Immunology.
41:1964-1968.
2021
|
|
| 2021
|
A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
European Respiratory Journal.
58.
2021
|
|
| 2021
|
Pulmonary artery enlargement is associated with exacerbations and mortality in ever-smokers with preserved ratio impaired spirometry.
American Journal of Respiratory and Critical Care Medicine.
204:481-485.
2021
|
|
| 2021
|
Study protocol for a national cohort of adults focused on respiratory health: The American Lung Association Lung Health Cohort (ALA-LHC) Study.
BMJ Open.
11.
2021
|
|
| 2021
|
Association between Cardiorespiratory Fitness and Bronchiectasis at CT: A Long-term Population-based Study of Healthy Young Adults Aged 18–30 Years in the CARDIA Study.
Radiology.
300:190-196.
2021
|
|
| 2021
|
Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.
Chest.
160:94-103.
2021
|
|
| 2021
|
Binge drinking moderates the association between chronic lung disease and e-cigarette use
2021
|
|
| 2021
|
Respiratory exacerbations are associated with muscle loss in current and former smokers.
Thorax.
76:554-560.
2021
|
|
| 2021
|
Triple Versus Dual Combination Therapy in Chronic Obstructive Pulmonary Disease in Asian Countries: Analysis of the IMPACT Trial.
Pulmonary Therapy.
7:101-118.
2021
|
|
| 2021
|
Risk of exacerbation and pneumonia with single-inhaler triple versus dual therapy in IMPACT.
Annals of the American Thoracic Society.
18:788-798.
2021
|
|
| 2021
|
COPD: COagulation-associated Pulmonary Disease?.
Respirology.
26:290-291.
2021
|
|
| 2021
|
Urban–Rural Disparities in Deaths from Chronic Lower Respiratory Disease in the United States.
American Journal of Respiratory and Critical Care Medicine.
203:769-772.
2021
|
|
| 2021
|
Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine.
Journal of Allergy and Clinical Immunology: In Practice.
9:1121-1132.e7.
2021
|
|
| 2021
|
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment Trial.
Chest.
159:985-995.
2021
|
|
| 2021
|
The influence of social support on COPD outcomes mediated by depression.
PLoS One.
16.
2021
|
|
| 2021
|
Association between inhaled corticosteroids and expiratory central airway collapse in smokers.
American Journal of Respiratory and Critical Care Medicine.
203:518-521.
2021
|
|
| 2021
|
A Patient Charter for Chronic Obstructive Pulmonary Disease.
Advances in Therapy.
38:11-23.
2021
|
|
| 2021
|
Conquest quality standards: For the collaboration on quality improvement initiative for achieving excellence in standards of copd care
2021
|
|
| 2021
|
InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD: Analysis of the Western Europe and North America Regions.
Chronic obstructive pulmonary diseases (Miami, Fla.).
8:76-90.
2021
|
|
| 2021
|
Losartan effects on emphysema progression randomized clinical trial: Rationale, design, recruitment, and retention.
Chronic obstructive pulmonary diseases (Miami, Fla.).
8:414-426.
2021
|
|
| 2021
|
Mucus plugs and emphysema in the pathophysiology of airflow obstruction and hypoxemia in smokers.
American Journal of Respiratory and Critical Care Medicine.
203:957-968.
2021
|
|
| 2021
|
Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis.
American Journal of Respiratory and Critical Care Medicine.
200:1402-1413.
2021
|
|
| 2021
|
Polycythemia is associated with lower incidence of severe COPD exacerbations in the SPIROMICS study.
Chronic obstructive pulmonary diseases (Miami, Fla.).
8:326-335.
2021
|
|
| 2021
|
Prognostic value of clinically important deterioration in copd: Impact trial analysis.
ERJ Open Research.
7.
2021
|
|
| 2021
|
Thank you all, now onwards and upwards!.
Chronic obstructive pulmonary diseases (Miami, Fla.).
8:303-305.
2021
|
|
| 2021
|
The presence of emphysema on chest imaging and mid-life cognition.
ERJ Open Research.
7.
2021
|
|
| 2020
|
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene.
Chest.
158:2333-2345.
2020
|
|
| 2020
|
Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects.
Scientific Reports.
10.
2020
|
|
| 2020
|
Endobronchial coils for emphysema: Dual mechanism of action on lobar residual volume reduction.
Respirology.
25:1160-1166.
2020
|
|
| 2020
|
The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study a randomized, double-blind, multicenter clinical trial.
American Journal of Respiratory and Critical Care Medicine.
202:1237-1243.
2020
|
|
| 2020
|
Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former Smokers.
Journal of Bone and Mineral Research.
35:1952-1961.
2020
|
|
| 2020
|
Clinical Investigator Training Program (CITP) – A practical and pragmatic approach to conveying clinical investigator competencies and training to busy clinicians.
Contemporary Clinical Trials Communications.
19.
2020
|
|
| 2020
|
Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Benefits and Risks.
Clinics in Chest Medicine.
41:475-484.
2020
|
|
| 2020
|
Reply to Suissa.
American Journal of Respiratory and Critical Care Medicine.
202:773-774.
2020
|
|
| 2020
|
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study.
Advances in Therapy.
37:3775-3790.
2020
|
|
| 2020
|
Effect of zephyr endobronchial valves on dyspnea, activity levels, and quality of life at one year: Results from a randomized clinical trial.
Annals of the American Thoracic Society.
17:829-838.
2020
|
|
| 2020
|
End-of-Life Spending and Healthcare Utilization Among Older Adults with Chronic Obstructive Pulmonary Disease.
American Journal of Medicine.
133:817-824.e1.
2020
|
|
| 2020
|
Smaller left ventricle size at noncontrast ct is associated with lower mortality in copdgene participants.
Radiology.
296:208-215.
2020
|
|
| 2020
|
Reduction in all-cause mortality with fluticasone furoate/umeclidinium/vilanterol in patients with chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
201:1508-1516.
2020
|
|
| 2020
|
Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults.
Immunity and Ageing.
17.
2020
|
|
| 2020
|
Classical and lectin complement pathways and markers of inflammation for investigation of susceptibility to infections among healthy older adults..
Immunity and Ageing.
17:18.
2020
|
|
| 2020
|
Association of Dysanapsis with Chronic Obstructive Pulmonary Disease among Older Adults.
Journal of the American Medical Association.
323:2268-2280.
2020
|
|
| 2020
|
Single-inhaler triple therapy fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol and umeclidinium/vilanterol in patients with COPD: Results on cardiovascular safety from the IMPACT trial.
Respiratory Research.
21.
2020
|
|
| 2020
|
Acute exacerbations of chronic obstructive pulmonary disease: In search of diagnostic biomarkers and treatable traits.
Thorax.
75:520-527.
2020
|
|
| 2020
|
The effect of exacerbation history on outcomes in the impact trial.
European Respiratory Journal.
55.
2020
|
|
| 2020
|
Heme metabolism genes Downregulated in COPD Cachexia.
Respiratory Research.
21.
2020
|
|
| 2020
|
Predicting Pneumonia in Chronic Obstructive Pulmonary Disease Have We Unraveled the Network of Risks?.
American Journal of Respiratory and Critical Care Medicine.
201:1026-1027.
2020
|
|
| 2020
|
Metoprolol for the Prevention of Exacerbations of COPD. Reply.
New England Journal of Medicine.
382:1375-1376.
2020
|
|
| 2020
|
A Qualitative Study of Pulmonary and Palliative Care Clinician Perspectives on Early Palliative Care in Chronic Obstructive Pulmonary Disease.
Journal of Palliative Medicine.
23:513-526.
2020
|
|
| 2020
|
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort.
Chest.
157:856-865.
2020
|
|
| 2020
|
Understanding the impact of chronic obstructive pulmonary disease exacerbations on patient health and quality of life.
European Journal of Internal Medicine.
73:1-6.
2020
|
|
| 2020
|
Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study.
American Journal of Medicine.
133:222-230.e11.
2020
|
|
| 2020
|
Disease progression modeling in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
201:294-302.
2020
|
|
| 2020
|
Exacerbations of chronic obstructive pulmonary disease: time to rename
2020
|
|
| 2020
|
Pulmonary artery enlargement and mortality risk in moderate to severe COPD: Results from COPDGene.
European Respiratory Journal.
55.
2020
|
|
| 2020
|
A risk prediction model for mortality among smokers in the COPDGene® study.
Chronic obstructive pulmonary diseases (Miami, Fla.).
7:346-361.
2020
|
|
| 2020
|
Association of Long-term Ambient Ozone Exposure with Respiratory Morbidity in Smokers.
JAMA Internal Medicine.
180:106-115.
2020
|
|
| 2020
|
Clinical development and research applications of the chronic obstructive pulmonary disease assessment test.
American Journal of Respiratory and Critical Care Medicine.
201:1058-1067.
2020
|
|
| 2020
|
Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
2020
|
|
| 2020
|
Efficacy and safety of the cftr potentiator icenticaftor (Qbw251) in copd: Results from a phase 2 randomized trial
2020
|
|
| 2020
|
Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study.
Respiratory Medicine.
161.
2020
|
|
| 2020
|
Immunoglobulin E as a biomarker for the overlap of atopic asthma and chronic obstructive pulmonary disease.
Chronic obstructive pulmonary diseases (Miami, Fla.).
7:1-12.
2020
|
|
| 2020
|
Novel respiratory disability score predicts copd exacerbations and mortality in the spiromics cohort
2020
|
|
| 2020
|
Plasma cathelicidin is independently associated with reduced lung function in COPD: Analysis of the subpopulations and intermediate outcome measures in COPD study cohort.
Chronic obstructive pulmonary diseases (Miami, Fla.).
7:370-381.
2020
|
|
| 2020
|
Reply to Gagnon et al..
American Journal of Respiratory and Critical Care Medicine.
201:120.
2020
|
|
| 2020
|
The association between neighborhood socioeconomic disadvantage and chronic obstructive pulmonary disease
2020
|
|
| 2020
|
The association of low income and high stress with acute care use in COPD patients.
Chronic obstructive pulmonary diseases (Miami, Fla.).
7:107-117.
2020
|
|
| 2019
|
Metoprolol for the prevention of acute exacerbations of COPD.
New England Journal of Medicine.
381:2304-2314.
2019
|
|
| 2019
|
COPD exacerbations and MACE: More than a chance encounter?.
Respirology.
24:1129-1130.
2019
|
|
| 2019
|
Reply to moy.
American Journal of Respiratory and Critical Care Medicine.
200:1443-1444.
2019
|
|
| 2019
|
The matrikine acetyl-proline-glycine-proline and clinical features of COPD: Findings from SPIROMICS.
Respiratory Research.
20.
2019
|
|
| 2019
|
Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS.
European Respiratory Journal.
54.
2019
|
|
| 2019
|
The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be a Better Predictor of COPD Exacerbations Compared With the Classic Definition.
Chest.
156:685-695.
2019
|
|
| 2019
|
A genetic risk score associated with chronic obstructive pulmonary disease susceptibility and lung structure on computed tomography.
American Journal of Respiratory and Critical Care Medicine.
200:721-731.
2019
|
|
| 2019
|
Adherence to Pulmonary Rehabilitation in COPD: A QUALITATIVE EXPLORATION of PATIENT PERSPECTIVES on BARRIERS and FACILITATORS.
Journal of Cardiopulmonary Rehabilitation and Prevention.
39:344-349.
2019
|
|
| 2019
|
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
2019
|
|
| 2019
|
Misinterpretation of time-to-first event curves can lead to inappropriate treatment.
European Respiratory Journal.
54.
2019
|
|
| 2019
|
Arterial vascular pruning, right ventricular size, and clinical outcomes in chronic obstructive pulmonary disease a longitudinal observational study.
American Journal of Respiratory and Critical Care Medicine.
200:454-461.
2019
|
|
| 2019
|
Chronic obstructive pulmonary disease in America's black population.
American Journal of Respiratory and Critical Care Medicine.
200:423-430.
2019
|
|
| 2019
|
Video telehealth pulmonary rehabilitation intervention in chronic obstructive pulmonary disease reduces 30-day readmissions.
American Journal of Respiratory and Critical Care Medicine.
200:511-513.
2019
|
|
| 2019
|
A formative evaluation of patient and family caregiver perspectives on early palliative care in chronic obstructive pulmonary disease across disease severity.
Annals of the American Thoracic Society.
16:1024-1033.
2019
|
|
| 2019
|
Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study.
Chest.
156:228-238.
2019
|
|
| 2019
|
Eosinophil-guided treatment of COPD exacerbations: unfinished business
2019
|
|
| 2019
|
The peak index: Spirometry metric for airflow obstruction severity and heterogeneity.
Annals of the American Thoracic Society.
16:982-989.
2019
|
|
| 2019
|
Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS.
PLoS One.
13.
2019
|
|
| 2019
|
Application of the community health worker model in adult asthma and COPD in the U.S.: A systematic review.
BMC Pulmonary Medicine.
19.
2019
|
|
| 2019
|
Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality.
Journal of the American Medical Association.
321:2438-2447.
2019
|
|
| 2019
|
It's more than low BMI: Prevalence of cachexia and associated mortality in COPD.
Respiratory Research.
20.
2019
|
|
| 2019
|
Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission
2019
|
|
| 2019
|
Determinants of cigarette smoking status in a national cohort of black and white adult ever smokers in the USA: A cross-sectional analysis of the REGARDS study.
BMJ Open.
9.
2019
|
|
| 2019
|
Predictors of Response to Endobronchial Coil Therapy in Patients With Advanced Emphysema.
Chest.
155:928-937.
2019
|
|
| 2019
|
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
Chest.
155:908-917.
2019
|
|
| 2019
|
Safety and tolerability of comprehensive research bronchoscopy in chronic obstructive pulmonary disease results from the SPIROMICS bronchoscopy substudy.
Annals of the American Thoracic Society.
16:439-446.
2019
|
|
| 2019
|
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study.
Chest.
155:519-527.
2019
|
|
| 2019
|
Effect of daily azithromycin therapy and adherence on readmission risk in COPD.
European Respiratory Journal.
53.
2019
|
|
| 2019
|
Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort.
Journal of Psychosomatic Research.
118:18-26.
2019
|
|
| 2019
|
Alignment of inhaled chronic obstructive pulmonary disease therapies with published strategies :analysis of the Global Initiative for Chronic Obstructive Lung Disease recommendations in SpiroMics.
Annals of the American Thoracic Society.
16:200-208.
2019
|
|
| 2019
|
Impact of pre-enrolment medication use on clinical outcomes in SUMMIT.
ERJ Open Research.
5.
2019
|
|
| 2019
|
Reducing chronic obstructive pulmonary disease hospital readmissions: An official American Thoracic Society workshop report.
Annals of the American Thoracic Society.
16:161-170.
2019
|
|
| 2019
|
Life-course smoking trajectories and risk for emphysema in middle age: The CARDIA Lung study.
American Journal of Respiratory and Critical Care Medicine.
199:237-240.
2019
|
|
| 2019
|
Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung.
Cell.
176:113-126.e15.
2019
|
|
| 2019
|
Acquired cystic fibrosis transmembrane conductance regulator dysfunction and radiographic bronchiectasis in current and former smokers: A cross-sectional study.
Annals of the American Thoracic Society.
16:150-153.
2019
|
|
| 2019
|
COPDGene® 2019: Redefining the diagnosis of chronic obstructive pulmonary disease.
Chronic obstructive pulmonary diseases (Miami, Fla.).
6:384-399.
2019
|
|
| 2019
|
Clinical significance of bronchodilator responsiveness evaluated by forced vital capacity in COPD: SPIROMICS cohort analysis
2019
|
|
| 2019
|
Combined forced expiratory volume in 1 second and forced vital capacity bronchodilator response, exacerbations, and mortality in chronic obstructive pulmonary disease.
Annals of the American Thoracic Society.
16:826-835.
2019
|
|
| 2019
|
Cost-effectiveness of once-daily single-inhaler triple therapy in COPD: The IMPACT trial
2019
|
|
| 2019
|
Inflammation and endothelial activation in early adulthood are associated with future emphysema: The CARDIA Lung Study.
European Respiratory Journal.
53.
2019
|
|
| 2019
|
Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
2019
|
|
| 2019
|
Velocity transfer function in the right pulmonary artery and impaired cardiopulmonary reserve in COPD
2019
|
|
| 2018
|
Centrilobular emphysema and coronary artery calcification: Mediation analysis in the SPIROMICS cohort.
Respiratory Research.
19.
2018
|
|
| 2018
|
Airway fractal dimension predicts respiratory morbidity and mortality in COPD.
Journal of Clinical Investigation.
128:5374-5382.
2018
|
|
| 2018
|
Erratum: Airway fractal dimension predicts respiratory morbidity and mortality in COPD (Journal of Clinical Investigation (2018) 128:12 (5374–5382) DOI: 10.1172/JCI120693).
Journal of Clinical Investigation.
128:5676.
2018
|
|
| 2018
|
Genomics and response to long-term oxygen therapy in chronic obstructive pulmonary disease.
Journal of Molecular Medicine.
96:1375-1385.
2018
|
|
| 2018
|
Longitudinal phenotypes and mortality in preserved ratio impaired spirometry in the COPDGene study.
American Journal of Respiratory and Critical Care Medicine.
198:1397-1405.
2018
|
|
| 2018
|
Lung function in young adults and risk of cardiovascular events over 29 years: The CARDIA study.
Journal of the American Heart Association.
7.
2018
|
|
| 2018
|
New Spirometry Indices for Detecting Mild Airflow Obstruction.
Scientific Reports.
8.
2018
|
|
| 2018
|
Occupational exposures and computed tomographic imaging characteristics in the SpiromICS cohort.
Annals of the American Thoracic Society.
15:1411-1419.
2018
|
|
| 2018
|
Unique Lipid Signatures of Extracellular Vesicles from the Airways of Asthmatics.
Scientific Reports.
8.
2018
|
|
| 2018
|
Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene.
JCI Insight.
3.
2018
|
|
| 2018
|
Heme scavenging reduces pulmonary endoplasmic reticulum stress, fibrosis, and emphysema.
JCI Insight.
3.
2018
|
|
| 2018
|
A multicenter randomized controlled trial of Zephyr Endobronchial Valve treatment in heterogeneous emphysema (LIBERATE).
American Journal of Respiratory and Critical Care Medicine.
198:1151-1164.
2018
|
|
| 2018
|
Interpreting Recent Developments in COPD Treatments
2018
|
|
| 2018
|
Interpreting Recent Developments in COPD Treatments.
2018
|
|
| 2018
|
Visual Estimate of Coronary Artery Calcium Predicts Cardiovascular Disease in COPD.
Chest.
154:579-587.
2018
|
|
| 2018
|
Defining impaired respiratory health a paradigm shift for pulmonary medicine.
American Journal of Respiratory and Critical Care Medicine.
198:440-446.
2018
|
|
| 2018
|
Genome-wide association study of lung function and clinical implication in heavy smokers.
BMC Medical Genomics.
19.
2018
|
|
| 2018
|
Interstitial features at chest CT enhance the deleterious effects of emphysema in the COPDGene cohort.
Radiology.
288:600-609.
2018
|
|
| 2018
|
Exacerbations of chronic obstructive pulmonary disease and cardiac events a post hoc cohort analysis from the SUMMIT randomized clinical trial.
American Journal of Respiratory and Critical Care Medicine.
198:51-57.
2018
|
|
| 2018
|
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort.
Respiratory Medicine.
140:87-93.
2018
|
|
| 2018
|
Rural residence and chronic obstructive pulmonary disease exacerbations: Analysis of the SPIROMICS cohort.
Annals of the American Thoracic Society.
15:808-815.
2018
|
|
| 2018
|
Respiratory symptoms in young adults and future lung disease the cardia lung study.
American Journal of Respiratory and Critical Care Medicine.
197:1616-1624.
2018
|
|
| 2018
|
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS..
Annals of the American Thoracic Society.
15:710-717.
2018
|
|
| 2018
|
Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.
Journal of Allergy and Clinical Immunology.
141:2037-2047.e10.
2018
|
|
| 2018
|
B-blocker therapy and clinical outcomes in patients with moderate chronic obstructive pulmonary disease and heightened cardiovascular risk an observational substudy of SUMMIT.
Annals of the American Thoracic Society.
15:608-614.
2018
|
|
| 2018
|
Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years.
Thorax.
73:414-421.
2018
|
|
| 2018
|
Paratracheal paraseptal emphysema and expiratory central airway collapse in smokers.
Annals of the American Thoracic Society.
15:479-484.
2018
|
|
| 2018
|
Single-inhaler triple therapy in symptomatic COPD patients: FULFIL subgroup analyses.
ERJ Open Research.
4.
2018
|
|
| 2018
|
Simultaneous LC–MS/MS analysis of eicosanoids and related metabolites in human serum, sputum and BALF.
Biomedical Chromatography.
32.
2018
|
|
| 2018
|
Survival of Lung Transplant Candidates With COPD: BODE Score Reconsidered.
Chest.
153:697-701.
2018
|
|
| 2018
|
The "Obesity paradox" in chronic obstructive pulmonary disease: Can it be resolved?.
Annals of the American Thoracic Society.
15:158-159.
2018
|
|
| 2018
|
Association of thrombocytosis with COPD morbidity: The SPIROMICS and COPDGene cohorts.
Respiratory Research.
19.
2018
|
|
| 2018
|
CT measurements of central pulmonary vasculature as predictors of severe exacerbation in COPD.
Medicine.
97.
2018
|
|
| 2018
|
Cigarette smoking and response to inhaled corticosteroids in COPD.
European Respiratory Journal.
51.
2018
|
|
| 2018
|
Clinical differences in COPD patients with variable patterns of hypoxemia.
Chronic obstructive pulmonary diseases (Miami, Fla.).
5:167-178.
2018
|
|
| 2018
|
Life-space mobility and clinical outcomes in COPD
2018
|
|
| 2018
|
Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression.
Chest.
153:65-76.
2018
|
|
| 2018
|
Once-daily single-inhaler triple versus dual therapy in patients with COPD.
New England Journal of Medicine.
378:1671-1680.
2018
|
|
| 2018
|
Race and gender disparities are evident in COPD underdiagnoses across all severities of measured airflow obstruction.
Chronic obstructive pulmonary diseases (Miami, Fla.).
5:177-184.
2018
|
|
| 2018
|
The long-term oxygen treatment trial for chronic obstructive pulmonary disease: Rationale, design, and lessons learned.
Annals of the American Thoracic Society.
15:89-101.
2018
|
|
| 2018
|
The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: A cohort study
2018
|
|
| 2017
|
Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort
2017
|
|
| 2017
|
Chest computed tomography-derived low fat-free mass index and mortality in COPD.
European Respiratory Journal.
50.
2017
|
|
| 2017
|
Implications of DRG Classification in a Bundled Payment Initiative for COPD.
2017
|
|
| 2017
|
Signs of gas trapping in normal lung density regions in smokers.
American Journal of Respiratory and Critical Care Medicine.
196:1404-1410.
2017
|
|
| 2017
|
Social Determinants of Adherence to Pulmonary Rehabilitation for Chronic Obstructive Pulmonary Disease.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
14:610-617.
2017
|
|
| 2017
|
Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.
Biomarker Insights.
12.
2017
|
|
| 2017
|
Computed tomography measure of lung at risk and lung function decline in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
196:569-576.
2017
|
|
| 2017
|
Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.
Journal of Allergy and Clinical Immunology.
140:710-719.
2017
|
|
| 2017
|
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort
2017
|
|
| 2017
|
Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
Respiratory Research.
18.
2017
|
|
| 2017
|
Measuring nitrate reductase activity from human and rodent tongues.
Nitric Oxide: Biology and Chemistry.
66:62-70.
2017
|
|
| 2017
|
Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD
2017
|
|
| 2017
|
Association between cardiorespiratory fitness and lung health from young adulthood to middle ages.
American Journal of Respiratory and Critical Care Medicine.
195:1236-1243.
2017
|
|
| 2017
|
Design of the subpopulations and intermediate outcome measures in COPD (SPIROMICS) AIR study.
BMJ Open Respiratory Research.
4.
2017
|
|
| 2017
|
Respiratory symptoms items from the COPD assessment test identify ever-smokers with preserved lung function at higher risk for poor respiratory outcomes an analysis of the subpopulations and intermediate outcome measures in COPD Study cohort.
Annals of the American Thoracic Society.
14:636-642.
2017
|
|
| 2017
|
Results of a Medicare Bundled Payments for care Improvement initiative for chronic obstructive pulmonary disease readmissions.
Annals of the American Thoracic Society.
14:643-648.
2017
|
|
| 2017
|
Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers.
Academic Radiology.
24:594-602.
2017
|
|
| 2017
|
Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstruction.
American Journal of Respiratory and Critical Care Medicine.
195:881-888.
2017
|
|
| 2017
|
Lung Mass in Smokers.
Academic Radiology.
24:386-392.
2017
|
|
| 2017
|
Gender differences in first and secondhand smoke exposure, spirometric lung function and cardiometabolic health in the old order Amish: A novel population without female smoking.
PLoS One.
12.
2017
|
|
| 2017
|
Sex-based genetic association study identifies celsr1 as a possible chronic obstructive pulmonary disease risk locus among women.
American Journal of Respiratory Cell and Molecular Biology.
56:332-341.
2017
|
|
| 2017
|
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease.
Respiratory Research.
18.
2017
|
|
| 2017
|
Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
195:324-330.
2017
|
|
| 2017
|
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPD
2017
|
|
| 2017
|
Biomechanical CT metrics are associated with patient outcomes in COPD.
Thorax.
72:409-414.
2017
|
|
| 2017
|
Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burden.
Annals of the American Thoracic Society.
14:26-32.
2017
|
|
| 2016
|
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
Respiratory Research.
17.
2016
|
|
| 2016
|
Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: A cohort study.
BMC Pulmonary Medicine.
16.
2016
|
|
| 2016
|
CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and Emphysema.
Academic Radiology.
23:1255-1263.
2016
|
|
| 2016
|
A ferret model of COPD-related chronic bronchitis.
JCI Insight.
1.
2016
|
|
| 2016
|
Beta-blockers in COPD: Time for reappraisal.
European Respiratory Journal.
48:880-888.
2016
|
|
| 2016
|
Cardiovascular disease in COPD: time to quash a silent killer
2016
|
|
| 2016
|
A phase III randomised controlled trial of single-dose triple therapy in COPD: The IMPACT protocol.
European Respiratory Journal.
48:320-330.
2016
|
|
| 2016
|
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD.
PLoS Genetics.
12.
2016
|
|
| 2016
|
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study
2016
|
|
| 2016
|
Association between functional small airway disease and FEV1 decline in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
194:178-184.
2016
|
|
| 2016
|
Persistent and newly developed chronic bronchitis are associated with worse outcomes in chronic obstructive pulmonary disease.
Annals of the American Thoracic Society.
13:1016-1025.
2016
|
|
| 2016
|
Meeting the challenge of COPD care delivery in the USA: A multiprovider perspective
2016
|
|
| 2016
|
Pilot evaluation of ivacaftor for chronic bronchitis
2016
|
|
| 2016
|
β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): A randomised controlled study protocol.
BMJ Open.
6.
2016
|
|
| 2016
|
Effect of endobronchial coils vs usual care on exercise tolerance in patients with severe emphysema: The renew randomized clinical trial.
Journal of the American Medical Association.
315:2178-2189.
2016
|
|
| 2016
|
Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPD.
Chest.
149:1197-1204.
2016
|
|
| 2016
|
Serum eosinophils as a COPD biomarker: Ready for prime time?
2016
|
|
| 2016
|
Therapeutic approaches to acquired cystic fibrosis transmembrane conductance regulator dysfunction in Chronic bronchitis.
Annals of the American Thoracic Society.
13:S169-S176.
2016
|
|
| 2016
|
Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis and Other Diseases of Mucus Clearance.
Clinics in Chest Medicine.
37:147-158.
2016
|
|
| 2016
|
Determinants of successful completion of pulmonary rehabilitation in COPD
2016
|
|
| 2016
|
Risk factors for COPD exacerbations in inhaled medication users: The COPDGene study biannual longitudinal follow-up prospective cohort.
BMC Pulmonary Medicine.
16.
2016
|
|
| 2016
|
Association between expiratory central airway collapse and respiratory outcomes among smokers.
Journal of the American Medical Association.
315:498-505.
2016
|
|
| 2016
|
Depression is associated with readmission for acute exacerbation of chronic obstructive pulmonary disease.
Annals of the American Thoracic Society.
13:197-203.
2016
|
|
| 2016
|
Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease.
Respiratory Medicine.
111:30-38.
2016
|
|
| 2016
|
COPD Overlap Syndromes: Asthma and Beyond..
Chronic obstructive pulmonary diseases (Miami, Fla.).
3:459-465.
2016
|
|
| 2016
|
Arterial and venous pulmonary vascular morphology and their relationship to findings in cardiac magnetic resonance imaging in smokers
2016
|
|
| 2016
|
Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.
Respiratory Research.
17:1-12.
2016
|
|
| 2016
|
Sex-specific features of emphysema among current and former smokers with COPD.
European Respiratory Journal.
47:104-112.
2016
|
|
| 2016
|
β-Blockers are associated with a reduction in COPD exacerbations.
Thorax.
71:8-14.
2016
|
|
| 2015
|
Recovery of acquired cystic fibrosis transmembrane conductance regulator dysfunction after smoking cessation.
American Journal of Respiratory and Critical Care Medicine.
192:1521-1524.
2015
|
|
| 2015
|
Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
Respiratory Research.
16.
2015
|
|
| 2015
|
Anticholinergic vs long-acting β-Agonist in combination with inhaled corticosteroids in black adults with asthma: The BELT randomized clinical trial.
Journal of the American Medical Association.
314:1720-1730.
2015
|
|
| 2015
|
Benefits of completing pulmonary rehabilitation in patients with asthma.
Journal of Asthma.
52:969-973.
2015
|
|
| 2015
|
A randomized, placebo-controlled trial of roflumilast effect on proline-glycine-proline and neutrophilic inflammation in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
192:934-942.
2015
|
|
| 2015
|
A randomised trial of lung sealant versus medical therapy for advanced emphysema.
European Respiratory Journal.
46:651-662.
2015
|
|
| 2015
|
Clinical and radiologic disease in smokers with normal spirometry.
JAMA Internal Medicine.
175:1539-1549.
2015
|
|
| 2015
|
Blood eosinophil counts as markers of response to inhaled corticosteroids in COPD? - Authors' reply
2015
|
|
| 2015
|
Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: A secondary analysis of data from two parallel randomised controlled trials
2015
|
|
| 2015
|
Commentary on "Factors associated with emergency department visits in asthma exacerbation".
Southern Medical Journal.
108:281-282.
2015
|
|
| 2015
|
Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.
Circulation: Cardiovascular Imaging.
8.
2015
|
|
| 2015
|
Executive Summary: Prevention of Acute Exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.
Chest.
147:883-893.
2015
|
|
| 2015
|
Prevention of Acute Exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.
Chest.
147:894-942.
2015
|
|
| 2015
|
IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.
American Journal of Respiratory Cell and Molecular Biology.
52:365-376.
2015
|
|
| 2015
|
Subsets of airway myeloid-derived regulatory cells distinguish mild asthma from chronic obstructive pulmonary disease.
Journal of Allergy and Clinical Immunology.
135:413-424.e15.
2015
|
|
| 2015
|
Lung cancer screening, version 1.2015: Featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN.
13:23-34.
2015
|
|
| 2015
|
Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD.
Annals of the American Thoracic Society.
12:27-34.
2015
|
|
| 2014
|
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction: Authors' response.
Thorax.
69:1147-1148.
2014
|
|
| 2014
|
Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.
American Journal of Respiratory Cell and Molecular Biology.
51:678-687.
2014
|
|
| 2014
|
Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease.
Annals of the American Thoracic Society.
11:1387-1394.
2014
|
|
| 2014
|
Radiological correlates and clinical implications of the paradoxical lung function response to β2 agonists: An observational study
2014
|
|
| 2014
|
Cardiovascular disease in COPD: A call for action
2014
|
|
| 2014
|
Prediction of acute respiratory disease in current and former smokers with and without COPD.
Chest.
146:941-950.
2014
|
|
| 2014
|
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.
Respiratory Research.
15.
2014
|
|
| 2014
|
Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease.
Respiratory Research.
15.
2014
|
|
| 2014
|
DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.
Respiratory Research.
15.
2014
|
|
| 2014
|
Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.
Respiratory Research.
15.
2014
|
|
| 2014
|
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy.
American Journal of Respiratory and Critical Care Medicine.
189:1503-1508.
2014
|
|
| 2014
|
Clinical and computed tomographic predictors of chronic bronchitis in COPD: A cross sectional analysis of the COPDGene study.
Respiratory Research.
15.
2014
|
|
| 2014
|
Computed tomographic measures of airway morphology in smokers and never-smoking normals.
Journal of Applied Physiology.
116:668-673.
2014
|
|
| 2014
|
Acquired defects in CFTR-dependent β-adrenergic sweat secretion in chronic obstructive pulmonary disease.
Respiratory Research.
15.
2014
|
|
| 2014
|
Impact of heterozygote CFTR Mutations in COPD patients with Chronic Bronchitis.
Respiratory Research.
15.
2014
|
|
| 2014
|
Pooled subpopulation analyses of the effects of roflumilast on exacerbations and lung function in COPD.
Respiratory Medicine.
108:366-375.
2014
|
|
| 2014
|
Determinants of arterial stiffness in COPD.
BMC Pulmonary Medicine.
14.
2014
|
|
| 2014
|
CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD.
Chest.
145:824-832.
2014
|
|
| 2014
|
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.
Thorax.
69:409-414.
2014
|
|
| 2014
|
Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.
American Journal of Respiratory Cell and Molecular Biology.
50:549-558.
2014
|
|
| 2014
|
Development and maintenance of a biospecimen repository for clinical samples derived from pulmonary patients.
Clinical and Translational Science.
7:336-341.
2014
|
|
| 2014
|
Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients.
Respiratory Medicine.
108:1171-1179.
2014
|
|
| 2014
|
FEV1/FEV6to diagnose airflow obstruction: Comparisons with computed tomography and morbidity indices.
Annals of the American Thoracic Society.
11:335-341.
2014
|
|
| 2014
|
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
New England Journal of Medicine.
370:2201-2210.
2014
|
|
| 2014
|
The efficacy of restaging endobronchial ultrasound in patients with non-small cell lung cancer after preoperative therapy.
Annals of Thoracic Surgery.
98:1008-1012.
2014
|
|
| 2014
|
Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.
European Respiratory Journal.
43:295-298.
2014
|
|
| 2013
|
Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function.
American Journal of Respiratory and Critical Care Medicine.
188:1321-1330.
2013
|
|
| 2013
|
Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations.
BMJ Open.
3.
2013
|
|
| 2013
|
AECOPD: Acute exacerbations of chronic obstructive cardiopulmonary disease?.
American Journal of Respiratory and Critical Care Medicine.
188:1046-1048.
2013
|
|
| 2013
|
Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD
2013
|
|
| 2013
|
Heritability of pulmonary function estimated from pedigree and whole-genome markers.
Frontiers in Genetics.
4.
2013
|
|
| 2013
|
Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.
American Journal of Respiratory and Critical Care Medicine.
188:231-239.
2013
|
|
| 2013
|
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
10:400.
2013
|
|
| 2013
|
Erratum: Elevated levels of NO are localized to distal airways in asthma (Free Radical Biology and Medicine (2011) 50 (1679-1688)).
Free Radical Biology and Medicine.
58:45.
2013
|
|
| 2013
|
Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: Two replicate double-blind, parallel-group, randomised controlled trials
2013
|
|
| 2013
|
GOLD 2011 disease severity classification in COPDGene: A prospective cohort study
2013
|
|
| 2013
|
Racial differences in CT phenotypes in COPD.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
10:20-27.
2013
|
|
| 2013
|
Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD.
Chest.
144:498-506.
2013
|
|
| 2013
|
Author's reply
2013
|
|
| 2013
|
Chronic obstructive pulmonary disease and cardiovascular disease
2013
|
|
| 2013
|
Effect of emphysema on CT scan measures of airway dimensions in smokers.
Chest.
143:687-693.
2013
|
|
| 2012
|
The authors reply.
New England Journal of Medicine.
367:2254-2255.
2012
|
|
| 2012
|
Restrictive lung disease: Not restricted to the lung?.
International Journal of Tuberculosis and Lung Disease.
16:1280.
2012
|
|
| 2012
|
Restrictive lung disease: not restricted to the lung? [Editorial]..
International Journal of Tuberculosis and Lung Disease.
16:1280.
2012
|
|
| 2012
|
Pulmonary arterial enlargement and acute exacerbations of COPD.
New England Journal of Medicine.
367:913-921.
2012
|
|
| 2012
|
Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.
Clinical Infectious Diseases.
55.
2012
|
|
| 2012
|
Feasibility of exercising adults with asthma: a randomized pilot study
2012
|
|
| 2012
|
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease.
PLoS One.
7.
2012
|
|
| 2012
|
A combined pulmonary-radiology workshop for visual evaluation of COPD: Study design, chest CT findings and concordance with quantitative evaluation.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
9:151-159.
2012
|
|
| 2012
|
Influence of lightweight ambulatory oxygen on oxygen use and activity patterns of COPD patients receiving long-term oxygen therapy.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
9:3-11.
2012
|
|
| 2012
|
Lung volume reduction for advanced emphysema: Surgical and bronchoscopic approaches.
Southern Medical Journal.
105:56-61.
2012
|
|
| 2012
|
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease.
Thorax.
67:399-406.
2012
|
|
| 2012
|
Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort.
Chest.
141:867-875.
2012
|
|
| 2011
|
Quantitative CT assessment of emphysema and airways in relation to lung cancer risk.
Radiology.
261:950-959.
2011
|
|
| 2011
|
The clinical features of the overlap between COPD and asthma.
Respiratory Research.
12.
2011
|
|
| 2011
|
Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD.
Respiratory Medicine.
105:1322-1330.
2011
|
|
| 2011
|
Azithromycin for prevention of exacerbations of COPD.
New England Journal of Medicine.
365:689-698.
2011
|
|
| 2011
|
Elevated levels of NO are localized to distal airways in asthma.
Free Radical Biology and Medicine.
50:1679-1688.
2011
|
|
| 2011
|
Disease severity and symptoms among patients receiving monotherapy for COPD.
Primary Care Respiratory Journal.
20:46-53.
2011
|
|
| 2011
|
Randomized trial of zileuton for treatment of COPD exacerbations requiring hospitalization.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
8:21-29.
2011
|
|
| 2011
|
Genome-wide association study of smoking behaviours in patients with COPD.
Thorax.
66:894-902.
2011
|
|
| 2011
|
Racial differences in quality of life in patients with COPD.
Chest.
140:1169-1176.
2011
|
|
| 2011
|
The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease. Quantitative CT analysis.
Academic Radiology.
18:40-46.
2011
|
|
| 2010
|
CT emphysema predicts thoracic aortic calcification in smokers with and without COPD.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
7:404-410.
2010
|
|
| 2010
|
Determining the optimal pneumococcal vaccination strategy for adults: Is there a role for the pneumococcal conjugate vaccine?.
Chest.
138:486-490.
2010
|
|
| 2010
|
Lung Function in Young Adults Predicts Airflow Obstruction 20 Years Later.
American Journal of Medicine.
123.
2010
|
|
| 2010
|
Safety and efficacy of an inhaled epidermal growth factor receptor inhibitor (BIBW 2948 BS) in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
181:438-445.
2010
|
|
| 2010
|
Biologic lung volume reduction therapy for advanced homogeneous emphysema.
European Respiratory Journal.
36:20-27.
2010
|
|
| 2010
|
Quantitative CT Measurement of Cross-sectional Area of Small Pulmonary Vessel in COPD. Correlations with Emphysema and Airflow Limitation.
Academic Radiology.
17:93-99.
2010
|
|
| 2010
|
Quantitative assessment of bronchial wall attenuation with thin-section CT: An indicator of airflow limitation in chronic obstructive pulmonary disease.
American Journal of Roentgenology.
195:363-369.
2010
|
|
| 2010
|
The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer.
Annals of Thoracic Surgery.
90:427-434.
2010
|
|
| 2009
|
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
American Journal of Respiratory and Critical Care Medicine.
180:499-505.
2009
|
|
| 2009
|
Airway wall attenuation: A biomarker of airway disease in subjects with COPD.
Journal of Applied Physiology.
107:185-191.
2009
|
|
| 2009
|
N-α-PGP and PGP, potential biomarkers and therapeutic targets for COPD.
Respiratory Research.
10.
2009
|
|
| 2009
|
Biologic lung volume reduction in advanced upper lobe emphysema phase 2 results.
American Journal of Respiratory and Critical Care Medicine.
179:791-798.
2009
|
|
| 2009
|
Racial and sex differences in chronic obstructive pulmonary disease susceptibility, diagnosis, and treatment.
Current Opinion in Pulmonary Medicine.
15:100-104.
2009
|
|
| 2009
|
Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting.
2009
|
|
| 2008
|
Authors' response.
Indian Journal of Medical Research.
63:1026.
2008
|
|
| 2008
|
Primary Care of the Patient with Chronic Obstructive Pulmonary Disease-Part 4: Understanding the Clinical Manifestations of a Progressive Disease.
American Journal of Medicine.
121.
2008
|
|
| 2008
|
Asthma exacerbations in African Americans treated for 1 year with combination fluticasone propionate and salmeterol or fluticasone propionate alone.
Current Medical Research and Opinion.
24:1669-1682.
2008
|
|
| 2008
|
Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Thorax.
63:301-305.
2008
|
|
| 2008
|
Studying COPD in African-Americans: Better late than never.
COPD: Journal of Chronic Obstructive Pulmonary Disease.
5:1-3.
2008
|
|
| 2008
|
Authors' response.
Indian Journal of Medical Research.
63:1027.
2008
|
|
| 2008
|
Pneumococcal vaccination for patients with COPD: Current practice and future directions.
Chest.
133:767-774.
2008
|
|
| 2007
|
Gender differences in the severity of CT emphysema in COPD.
Chest.
132:464-470.
2007
|
|
| 2006
|
COPD: Racial Disparities in Susceptibility, Treatment, and Outcomes.
Clinics in Chest Medicine.
27:463-471.
2006
|
|
| 2006
|
Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease.
Respiratory Medicine.
100:1110-1116.
2006
|
|
| 2006
|
An unusual cause of chronic cough: Foreign body aspiration.
Journal of General Internal Medicine.
21.
2006
|
|
| 2006
|
Improving the lung cancer resection rate in the US department of Veterans Affairs health system.
Clinical Lung Cancer.
7:268-272.
2006
|
|
| 2005
|
Maintenance pharmacotherapy of chronic obstructive pulmonary disease: An evidence-based approach.
Expert Opinion on Pharmacotherapy.
6:13-25.
2005
|
|
| 2004
|
Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.
Expert Opinion on Pharmacotherapy.
5:1815-1826.
2004
|
|
| 2004
|
Standardized guidelines for surveillance bronchoscopy reduce complications in lung transplant recipients.
Journal of Heart and Lung Transplantation.
23:110-114.
2004
|
|
| 2003
|
A Mycotic Pulmonary Artery Aneurysm Presenting as an Endobronchial Mass.
Chest.
124:1610-1612.
2003
|
|
